Francisco J Salguero Selected Research

Francisco J Salguero Research Topics

Disease

28	Infections 06/2022 - 05/2004
9	COVID-19 01/2022 - 10/2020
6	Tuberculosis (Tuberculoses) 01/2021 - 07/2011
6	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 07/2009
4	Human Influenza (Influenza) 01/2022 - 01/2018
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006 - 01/2004
3	Melioidosis 12/2017 - 07/2011
2	Coinfection 08/2021 - 01/2021
2	Granuloma 01/2021 - 07/2011
2	Weight Loss (Weight Reduction) 01/2021 - 01/2020
2	Necrosis 01/2019 - 02/2013
2	Neoplasms (Cancer) 01/2018 - 10/2013
2	Hepatitis 10/2015 - 04/2013
2	Bovine Spongiform Encephalopathy (Mad Cow Disease) 01/2006 - 05/2004
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Disease Progression 01/2021
1	Bovine Tuberculosis 01/2021
1	Hantavirus Infections 10/2020
1	Critical Illness (Critically Ill) 10/2019
1	Latent Infection 01/2018
1	Cognitive Dysfunction 01/2018
1	Carcinogenesis 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Orthomyxoviridae Infections 10/2016
1	Edema (Dropsy) 10/2015
1	Fibrosis (Cirrhosis) 10/2015
1	Visceral Leishmaniasis (Kala Azar) 09/2015
1	Leishmaniasis 09/2015
1	Foot-and-Mouth Disease 11/2014
1	Classical Swine Fever (Swine Fever) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2013
1	Fever (Fevers) 04/2013
1	Body Weight (Weight, Body) 01/2012
1	Persistent Infection 07/2011
1	Viremia 07/2009

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 06/2022 - 02/2013
8	CytokinesIBA 01/2021 - 07/2009
6	AerosolsIBA 08/2021 - 01/2012
4	EnzymesIBA 01/2020 - 04/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2006
4	Prion ProteinsIBA 11/2006 - 05/2004
3	Interleukin-10 (Interleukin 10)IBA 10/2015 - 07/2009
3	Interferon-gamma (Interferon, gamma)IBA 10/2014 - 07/2009
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2021 - 01/2006
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2018
2	DNA VaccinesIBA 01/2021 - 09/2015
2	Interferon Type IIBA 01/2021 - 10/2014
2	Biological ProductsIBA 08/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 03/2017 - 07/2011
2	CollagenIBA 10/2015 - 07/2011
1	Subgenomic RNAIBA 01/2022
1	Single-Domain AntibodiesIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	EpitopesIBA 01/2021
1	reluscovtogene ralaplasmidIBA 01/2021
1	Immune Sera (Antisera)IBA 01/2021
1	AcidsIBA 12/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2020
1	Immunoglobulin A (IgA)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	InterferonsIBA 01/2019
1	AntigensIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Tuberculin (PPD)IBA 01/2018
1	imidazoloneIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	LipidsIBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 10/2015
1	Pharmaceutical PreparationsIBA 09/2015
1	Immunologic Factors (Immunomodulators)IBA 09/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2015
1	liposomal amphotericin B FDA Link 09/2015
1	Attenuated VaccinesIBA 04/2015
1	PerforinIBA 10/2014
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2013
1	Virus ReceptorsIBA 02/2013
1	HaptoglobinsIBA 02/2013
1	Interferon Receptors (Interferon Receptor)IBA 01/2012
1	RestonIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2011
1	Interferon-alpha (Interferon Alfa)IBA 07/2009
1	Interleukin-12 (IL 12)IBA 07/2009
1	PrebioticsIBA 01/2009
1	AntibodiesIBA 10/2006

Therapy/Procedure

7	Therapeutics 06/2022 - 04/2013
1	Intranasal Administration 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Immunotherapy 09/2015